Baltimore, MDNCT07594652Now EnrollingIRB Ready

ADHD - Attention Deficit Disorder With Hyperactivity Clinical Trial in Baltimore, MD

Access cutting-edge adhd - attention deficit disorder with hyperactivity treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.

Sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Quick Self-Assessment

See if you qualify for this Baltimore location

Preparing your pre-screening questions…

Expert Care in Baltimore

Access adhd - attention deficit disorder with hyperactivity specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related adhd - attention deficit disorder with hyperactivity treatment provided free

Apply for This Baltimore Location

Check if you qualify for this adhd - attention deficit disorder with hyperactivity clinical trial in Baltimore, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baltimore

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baltimore site if eligible
  4. 4Begin participation

About This ADHD - Attention Deficit Disorder With Hyperactivity Study in Baltimore

This is an observational study assessing the usage of stimulant medication for ADHD in the context of pediatric epilepsy.

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Who Can Participate

Inclusion Criteria

Established diagnosis of epilepsy that requires treatment with anti-seizure medication.
No episodes of seizure clusters or status epilepticus within 30 days prior to entry into the study.
Diagnosis of ADHD with functional impairment.
Good general health as determined by medical history and physical examination, including stable vital signs.
Participant or legal caregiver capable of providing informed consent and fully capable of monitoring the subject's disease process and compliance with treatment.

Exclusion Criteria

• Previous allergic or hypersensitivity reactions to stimulant medicines including Jornay PM®
Active substance abuse or dependence within 30 days of enrollment
Epilepsy that is unstable or with seizure frequency that exceeds four events per month, based on an average over the previous three months
DSM-V diagnosis of psychotic illness or imminent risk of harm to self or others.
Current use of stimulants to treat ADHD
Serious or unstable medical or neurologic conditions such as HIV, liver or kidney disease, cancer or diabetes.
Unstable cardiac illness such as arrythmias or cardiomyopathy.
Participation in a previous experimental drug study within 30 days of baseline visit.
Estimated IQ\<70 as indicated by clinical assessment to the degree that rating scales may be invalid
Insufficient capacity of caregiver or legal guardian to understand and appropriately consent for study procedures

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT07594652) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

ADHD - Attention Deficit Disorder With Hyperactivity Treatment Options in Baltimore, MD

If you're searching for adhd - attention deficit disorder with hyperactivity treatment options in Baltimore, MD, this clinical trial (NCT07594652) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced adhd - attention deficit disorder with hyperactivity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all adhd - attention deficit disorder with hyperactivity clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Baltimore, MD

See all pulmonary embolism clinical trials recruiting in Baltimore — not just this study.

Browse Pulmonary Embolism Trials in Baltimore →

Browse More Trials by Condition

Pulmonary Embolism TrialsAlzheimers Disease TrialsHuntingtons Disease TrialsADHD TrialsRheumatoid Arthritis TrialsAtopic Dermatitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Baltimore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baltimore, MD